Raymond James Financial’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7M Sell
211,655
-38,202
-15% -$1.78M ﹤0.01% 1947
2026
Q1
$9.02M Buy
249,857
+4,628
+2% +$194K ﹤0.01% 2109
2025
Q4
$11.6M Buy
245,229
+127,361
+108% +$5.38M ﹤0.01% 1841
2025
Q3
$3.83M Buy
117,868
+93,043
+375% +$3.32M ﹤0.01% 2657
2025
Q2
$1.02M Buy
24,825
+7,985
+47% +$308K ﹤0.01% 3572
2025
Q1
$703K Buy
16,840
+5,572
+49% +$290K ﹤0.01% 3725
2024
Q4
$661K Buy
+11,268
New +$666K ﹤0.01% 3725

Other funds holding BRKR

Raymond James Financial's BRKR Position: Q2 2026 in Review

Raymond James Financial reduced its Bruker (BRKR) stake by 15% in Q2 2026, selling an estimated $1.78M and leaving 211,655 shares worth $12.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1947.

Raymond James Financial first reported a position in BRKR in Q4 2024 and has held it in 7 quarters since. 415 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Raymond James Financial held 211,655 shares of Bruker worth $12.7M as of Q2 2026.
  • Raymond James Financial sold 38,202 Bruker shares in Q2 2026, an estimated $1.78M.
  • Bruker made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #1947 holding.
  • Raymond James Financial first reported a position in Bruker in Q4 2024 and has held it in 7 quarters since.
  • 415 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.